Huangpu project reaches milestone with completion of 1st phase buildings

The first phase of the Huangpu Life Science and Technology Port project saw the comprehensive topping-out of its initial batch of buildings on Nov 8, marking a new stage of development in the project's construction.

Located within the International Biomedical Innovation Park of the Sino-Singapore Guangzhou Knowledge City, the project is a hub for leading global biomedical companies, including well-known names like Innocare and BeiGene.

Rendering of the projects. [Photo/WeChat account: guangzhougaoxinqu]

Covering a total land area of 110 mu (7.33 hectares), with a total construction area of approximately 230,000 square meters and a total investment of around 1.8 billion yuan ($250.7 million), the project focuses on the "medical devices + pharmaceutical research and development (R&D) manufacturing" industry. It aims to create a high-quality development platform for the biopharmaceutical industry in the Greater Bay Area.

The construction of the project comprises research and development facilities, standalone headquarters buildings, and high-standard multi-story manufacturing structures. It is expected to be delivered and operational by 2025, offering a range of "one-stop" services such as research support and clinical trials.

Supporting facilities will include ecological green spaces, an industry showcase center, talent dormitories, cafeteria restaurants, and a library designed to empower industrial upgrading.

The future of the Huangpu Life Science and Technology Port project will revolve around areas such as high-end medical devices and pharmaceutical R&D manufacturing, aiming to create a more comprehensive industrial cluster.

Share - WeChat